Healius Ltd
HLS: XASX (AUS)
| Morningstar Rating for Stocks | Fair Value | Economic Moat | Capital Allocation |
|---|---|---|---|
| A$5.00 | Gvcv | Qtjjxlzl |
Healius’ Cost-Out Program Is Tracking Ahead of Expectations
Business Strategy and Outlook
In 2018 the former Primary Healthcare rebranded itself as Healius in an effort to signify the turnaround underway. The new CEO, appointed in 2017, is looking to new sources of strategic growth as well as dealing with prior underinvestment in systems, revamp of physical spaces and legacy issues with stakeholder management. There is much to fix in the business and we anticipate it to take two years to see the major benefits from the turnaround delivered in the financial results.